Atara Biotherapeutics Reports Early Findings of Potential Efficacy from Phase 1 Study of ATA188 in Patients with Progressive Multiple Sclerosis at ECTRIMS 2019

September 13, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search